Here, our studies provide several pieces of evidence that together indicate that a p38γ-activated ternary-complex with Hsp90 and K-Ras may be a novel therapeutic target for K-Ras dependent colon cancer. The gene discussed is HSP90AB1; the disease is malignant colon neoplasm.